Osaka Organic Chemical Industry (TSE:4187) has reported Q2 2026 revenue of ¥10.96b and basic EPS of ¥88.54, with trailing twelve month revenue of ¥38.90b and EPS of ¥385.42 framing the latest quarter in a wider earnings run-rate. The company has seen quarterly revenue move from ¥8.52b in Q1 2025 to ¥10.96b in Q2 2026, while basic EPS over the same period has ranged from ¥49.96 to ¥169.63, giving investors a clear view of how the top and bottom line have tracked through recent reporting periods. With a reported net profit margin of 20.2% over the last twelve months versus 12% a year earlier, the focus now turns to how the durability of these margins compares with forward expectations.
See our full analysis for Osaka Organic Chemical Industry.Next up, the numbers are set against the widely followed market and community narratives to see which views on Osaka Organic Chemical Industry hold up and which start to look stretched.
Curious how numbers become stories that shape markets? Explore Community Narratives
For a deeper read on how Osaka Organic Chemical Industry's valuation, growth outlook, and risks fit together, and to see different investor narratives in one place, it is worth checking out the broader community discussion Curious how numbers become stories that shape markets? Explore Community Narratives.
Don't just look at this quarter; the real story is in the long-term trend. We've done an in-depth analysis on Osaka Organic Chemical Industry's growth and its valuation to see if today's price is a bargain. Add the company to your watchlist or portfolio now so you don't miss the next big move.
If the mix of earnings headlines and one off gains around Osaka Organic Chemical Industry feels conflicting, now is a good time to review the figures in detail and stress test your own thesis using the 4 key rewards and 3 important warning signs.
Osaka Organic Chemical Industry faces a tension between a DCF value well below the ¥5,100 share price, one-off boosted earnings, and forecasts for earnings to decline.
If that mix of valuation signals and profit uncertainty feels uncomfortable, now may be a good time to review stocks in the 19 high quality undervalued stocks that better align with your expectations.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com